Mosa Selebalo

PERFORMANCE OF HIV DRUG RESISTANCE EARLY WARNING INDICATORS AND ASSOCIATED PROGRAM FACTORS IN LESOTHO DURING THE DOLUTEGRAVIR ERA

HIV drug resistance (HIVDR) remains a major threat to the long-term effectiveness of antiretroviral therapy (ART) programs, particularly in settings where routine resistance testing is limited. Although dolutegravir (DTG)-based regimens have improved treatment durability, program...